| Pharmaceutical Ingredients Manufacturing | Active pharmaceutical ingredients (12 APIs) and fine chemicals (6 types) production for domestic and export customers. | Established manufacturing sites with quality certifications and strong client relationships. | B2B; pharmaceutical manufacturers and chemical companies. | Specialized API production blocks. | 75 | 74 | Sale of bulk drugs and fine chemicals to pharma companies. | Direct sales with volume-based contracts. | Domestic pharma demand, export opportunities, capacity expansions. | |
| Real Estate and Construction | Investment and development activities in real estate and construction sector. | Access to capital from pharma divestment and management experience. | B2B and B2C real estate markets. | Project development in growth areas. | 10 | 10 | Project development gains and rental incomes. | Project-based revenues and recurring rentals. | Strategic investment infusion post divestment, rising demand in real estate. | |
| Clean and Renewable Energy | Clean energy projects and investments focused on renewable energy solutions. | First-mover advantage in local renewable energy investments. | Energy consumers and government programs. | Energy production with potential subsidies. | 10 | 10 | Energy sales and investment returns. | Contractual energy supply or project revenues. | Government push for renewables and sustainability trends. | |
| Capital Markets | Investments in securities and financial instruments. | Experienced promoters leveraging pharma divestment proceeds. | N/A (investment returns). | Portfolio gains from strategic investments. | 5 | 6 | Capital gains and dividend income. | Market-driven returns. | Active capital deployment with market opportunities. | |
